TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Xellia Pharmaceuticals AS
Closing information (x1000 EUR)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 7,772 | 7,839 | 8,487 |
Financial expenses | 2 | 3 | 886 |
Earnings before taxes | 2,567 | 2,804 | 756 |
Total assets | 60,868 | 57,371 | 55,932 |
Current assets | 15,189 | 12,320 | 10,571 |
Current liabilities | 2,149 | 2,064 | 2,254 |
Equity capital | 58,098 | 54,590 | 52,859 |
- share capital | 22,636 | 22,259 | 22,688 |
Employees (average) | 43 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 95.4% | 95.2% | 94.5% |
Turnover per employee | 197 | ||
Profit as a percentage of turnover | 33.0% | 35.8% | 8.9% |
Return on assets (ROA) | 4.2% | 4.9% | 2.9% |
Current ratio | 706.8% | 596.9% | 469.0% |
Return on equity (ROE) | 4.4% | 5.1% | 1.4% |
Change turnover | -200 | -488 | -87 |
Change turnover % | -3% | -6% | -1% |
Chg. No. of employees | -4 | ||
Chg. No. of employees % | -9% |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.